PEAK PHARMACEUTICALS, INC. Research and Development Expense
PEAK PHARMACEUTICALS, INC. (RMHI) reported Research and Development Expense of $13.05 thousand for the 12-month period ending 2015-09-30, per its 10-K filed 2016-01-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2016-02-18
- PEAK PHARMACEUTICALS, INC. research and development expense for the quarter ending 2015-09-30 was $908.00.
- PEAK PHARMACEUTICALS, INC. research and development expense for the quarter ending 2015-06-30 was $276.00.
- PEAK PHARMACEUTICALS, INC. research and development expense for the quarter ending 2015-03-31 was $11.34K.
- PEAK PHARMACEUTICALS, INC. research and development expense for the quarter ending 2014-12-31 was $532.00.
- PEAK PHARMACEUTICALS, INC. research and development expense for fiscal 2015 was $13.05K, a 56.50% decline from fiscal 2014.
- PEAK PHARMACEUTICALS, INC. research and development expense for fiscal 2014 was $30.00K.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2015-09-30 | $908.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-01-13 | $1.18K derived: sum of 2 quarters · filed 2016-01-13 | $12.52K derived: sum of 3 quarters · filed 2016-01-13 | $13.05K 10-K · filed 2016-01-13 |
| 2015-06-30 | $276.00 10-Q · filed 2015-08-13 | $11.61K derived: sum of 2 quarters · filed 2015-08-13 | $12.14K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $11.34K 10-Q · filed 2015-05-15 | $11.87K 10-Q · filed 2015-05-15 | ||
| 2014-12-31 | $532.00 10-Q · filed 2016-02-18 | |||
| 2014-09-30 | $30.00K 10-K · filed 2016-01-13 |